Across this series of dMMR Lynch syndrome spectrum cancers, double somatic genetic alterations explained 23% (n = 19) of cases overall and 49% (19/39) of those lacking causal germline variants, MLH1 promoter hypermethylation, and BRAF V600E, also known as Lynch-like syndrome. Here, MLH1 is linked to cancer.